Paradigm Biocapital Advisors LP
Position in OLMA — Olema Pharmaceuticals, Inc.
CIK 1855655
NEW YORK, NY
Position in OLMA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$108,468,905
-$11,117,883 QoQ
Shares Held
8,670,576
+8.1% QoQ
Ownership
9.91%
of shares outstanding
% of Portfolio
2.35%
of 13F equity value
Holder Rank
#2
of 182 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OLMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Paradigm Biocapital Advisors LP holds $4,608,890,546 across 28 Biotechnology names. OLMA ranks #16 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
6,361,323 | $1,191,348,571 | |
| 2 | EWTX |
Edgewise Therapeutics, Inc.
|
10,215,455 | $415,053,936 | |
| 3 | GMAB |
Genmab A/S
|
13,133,131 | $360,767,108 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
3,840,778 | $340,984,270 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
1,576,385 | $209,233,581 | |
| 6 | ORKA |
Oruka Therapeutics, Inc.
|
2,144,526 | $204,094,539 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
6,357,523 | $198,736,168 | |
| 8 | BLTE |
Belite Bio, Inc
|
1,232,877 | $189,844,564 |
All Filings in OLMA
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $108,468,905 | 8,670,576 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $119,586,788 | 8,020,576 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $188,604,300 | 7,544,172 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $66,514,943 | 6,794,172 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $28,815,372 | 6,764,172 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $25,346,806 | 6,741,172 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $43,313,139 | 7,429,355 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $42,587,975 | 7,304,970 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $65,712,984 | 5,503,600 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $85,516,952 | 7,903,600 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $89,468,752 | 7,903,600 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $110,887,508 | 7,903,600 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $96,374,460 | 7,803,600 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $33,691,345 | 3,731,046 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $8,266,848 | 2,382,377 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||